Quebec · CCAA
First Report of the Monitor, dated October 10, 2024
Court officer report · 10 October 2024
AI summary
A plain-English summary drawn only from this filing: what it is, why it matters, and the parties, amounts and dates it turns on.
What we verified from this filing6 verified
- cash on handnote: Figure is from the $CAD000 actual receipts and disbursements table (2,004 thousand CAD) · as at: 2024-10-04 · amount: 2004000 · currency: CAD
- operational summaryThe Applicants continue to operate in the ordinary course of business while pursuing a SISP for the sale or restructuring of substantially all of Valeo Pharma Inc. and VPI Pharmaceuticals Inc.'s assets, with Valeo Pharma Corp. remaining a dormant entity with little to no assets or operations.
- report date10 October 2024
- report noFirst Report of the Monitor
- sale advisorErnst & Young Inc.; Ernst & Young Orenda Corporate Finance (Canada) Inc.
- sale outcometext: SISP proposed for approval, not yet approved by the court · scope: whole_business · status: process_approved